HUE039044T2 - Gyógyászati kompozíció sclerosis multiplex kezelésére - Google Patents
Gyógyászati kompozíció sclerosis multiplex kezeléséreInfo
- Publication number
- HUE039044T2 HUE039044T2 HUE13710308A HUE13710308A HUE039044T2 HU E039044 T2 HUE039044 T2 HU E039044T2 HU E13710308 A HUE13710308 A HU E13710308A HU E13710308 A HUE13710308 A HU E13710308A HU E039044 T2 HUE039044 T2 HU E039044T2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- pharmaceutical composition
- multiple sclerosis
- sclerosis
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Rehabilitation Therapy (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL398077A PL398077A1 (pl) | 2012-02-10 | 2012-02-10 | Kompozycja farmaceutyczna oraz zastosowanie kompozycji do wytwarzania leku, do podawania naskórnego, do leczenia stwardnienia rozsianego |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE039044T2 true HUE039044T2 (hu) | 2018-12-28 |
Family
ID=46762685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE13710308A HUE039044T2 (hu) | 2012-02-10 | 2013-02-08 | Gyógyászati kompozíció sclerosis multiplex kezelésére |
Country Status (9)
Country | Link |
---|---|
US (2) | US20150080313A1 (hu) |
EP (1) | EP2812351B1 (hu) |
DK (1) | DK2812351T3 (hu) |
ES (1) | ES2684725T3 (hu) |
HU (1) | HUE039044T2 (hu) |
PL (2) | PL398077A1 (hu) |
PT (1) | PT2812351T (hu) |
SI (1) | SI2812351T1 (hu) |
WO (1) | WO2013117742A2 (hu) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2420833T3 (pl) * | 2006-05-05 | 2016-03-31 | Opexa Therapeutics | Szczepionka z komórek T |
TR201807084T4 (tr) * | 2008-01-25 | 2018-06-21 | Vianex S A | Terapötik aşılar. |
-
2012
- 2012-02-10 PL PL398077A patent/PL398077A1/pl unknown
-
2013
- 2013-02-08 US US14/377,903 patent/US20150080313A1/en not_active Abandoned
- 2013-02-08 PL PL13710308T patent/PL2812351T3/pl unknown
- 2013-02-08 HU HUE13710308A patent/HUE039044T2/hu unknown
- 2013-02-08 ES ES13710308.1T patent/ES2684725T3/es active Active
- 2013-02-08 WO PCT/EP2013/052615 patent/WO2013117742A2/en active Application Filing
- 2013-02-08 SI SI201331085T patent/SI2812351T1/sl unknown
- 2013-02-08 PT PT137103081T patent/PT2812351T/pt unknown
- 2013-02-08 EP EP13710308.1A patent/EP2812351B1/en active Active
- 2013-02-08 DK DK13710308.1T patent/DK2812351T3/en active
-
2018
- 2018-08-02 US US16/053,217 patent/US20190201484A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2812351A2 (en) | 2014-12-17 |
WO2013117742A3 (en) | 2014-02-20 |
SI2812351T1 (sl) | 2018-11-30 |
WO2013117742A2 (en) | 2013-08-15 |
PL398077A1 (pl) | 2012-08-27 |
US20150080313A1 (en) | 2015-03-19 |
EP2812351B1 (en) | 2018-03-28 |
PL2812351T3 (pl) | 2018-09-28 |
ES2684725T3 (es) | 2018-10-04 |
PT2812351T (pt) | 2018-08-01 |
DK2812351T3 (en) | 2018-07-09 |
US20190201484A1 (en) | 2019-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212632A1 (zh) | 用於治療 介導的疾病的藥物組合物 | |
HK1206297A1 (en) | Pharmaceutical compositions for combination therapy | |
SI3378862T1 (sl) | Dihidropirimidinoizokuinolini in farmacevtski sestavki le-teh za zdravljenje multiple skleroze | |
ZA201505443B (en) | Compositions containing phorbol esters for the treatment of stroke | |
HRP20190050T1 (hr) | Farmaceutski pripravci za kombinacijsku terapiju | |
HK1215794A1 (zh) | 用於治療疾病的同種異體自噬體富集組合物 | |
HRP20181761T1 (hr) | Novi pripravak alfentanila za liječenje akutne boli | |
ZA201408062B (en) | Compositions and methods for the treatment of multiple sclerosis | |
PL2814462T3 (pl) | Kompozycja farmaceutyczna na bazie oleju do leczenia chorób przewodu pokarmowego | |
SI2812351T1 (sl) | Farmacevtski sestavek za zdravljenje multiple skleroze | |
HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
GB201207476D0 (en) | pharmaceutical for the treatment of leishmaniasis | |
PT2814473T (pt) | Composições farmacêuticas para terapia de combinação | |
AU2011900519A0 (en) | Drug compositions for the treatment of insomnia |